H Kollberg

2.0k total citations
81 papers, 1.5k citations indexed

About

H Kollberg is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, H Kollberg has authored 81 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in H Kollberg's work include Cystic Fibrosis Research Advances (57 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (5 papers). H Kollberg is often cited by papers focused on Cystic Fibrosis Research Advances (57 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (5 papers). H Kollberg collaborates with scholars based in Sweden, Kuwait and Denmark. H Kollberg's co-authors include Per‐Erik Wejåker, David Carlander, Jon O. Lundberg, Kjell Alving, Eddie Weitzberg, S. L. Nordvall, Anders Larsson, Krister Hellsing, Hanne Vebert Olesen and Elin Nilsson and has published in prestigious journals such as PEDIATRICS, Clinica Chimica Acta and Archives of Disease in Childhood.

In The Last Decade

H Kollberg

79 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Kollberg Sweden 18 695 297 257 249 175 81 1.5k
M. C. Roberts United States 20 204 0.3× 146 0.5× 288 1.1× 112 0.4× 179 1.0× 62 1.2k
Shota Yamamoto Japan 26 193 0.3× 183 0.6× 312 1.2× 358 1.4× 289 1.7× 128 1.9k
Jill Beech United States 30 214 0.3× 149 0.5× 459 1.8× 351 1.4× 94 0.5× 105 2.6k
H. Platt United Kingdom 22 209 0.3× 84 0.3× 185 0.7× 149 0.6× 64 0.4× 61 1.2k
Manuela Rinaldi Belgium 16 300 0.4× 174 0.6× 108 0.4× 183 0.7× 43 0.2× 25 1.0k
Howard B. Gelberg United States 21 255 0.4× 51 0.2× 286 1.1× 194 0.8× 280 1.6× 72 1.4k
Myriam Bélanger Canada 25 176 0.3× 180 0.6× 105 0.4× 413 1.7× 183 1.0× 57 2.0k
Iwan A. Burgener Austria 23 434 0.6× 87 0.3× 290 1.1× 360 1.4× 254 1.5× 95 1.6k
M. Oikawa Japan 23 244 0.4× 69 0.2× 189 0.7× 200 0.8× 66 0.4× 152 1.7k
Brendan C. McKiernan United States 20 492 0.7× 242 0.8× 151 0.6× 108 0.4× 64 0.4× 56 1.0k

Countries citing papers authored by H Kollberg

Since Specialization
Citations

This map shows the geographic impact of H Kollberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kollberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kollberg more than expected).

Fields of papers citing papers by H Kollberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Kollberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kollberg. The network helps show where H Kollberg may publish in the future.

Co-authorship network of co-authors of H Kollberg

This figure shows the co-authorship network connecting the top 25 collaborators of H Kollberg. A scholar is included among the top collaborators of H Kollberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Kollberg. H Kollberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kollberg, H. (2015). Avian Antibodies (IgY) to Fight Antibiotic Resistance. Clinical Microbiology Open Access. 4(2). 4 indexed citations
2.
Pressler, Tacjana, Richard Conway, Niels Høiby, et al.. (2011). Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. Journal of Cystic Fibrosis. 10. S75–S78. 116 indexed citations
3.
Nilsson, Elin, Anders Larsson, Hanne Vebert Olesen, Per‐Erik Wejåker, & H Kollberg. (2008). Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatric Pulmonology. 43(9). 892–899. 91 indexed citations
4.
Nilsson, Elin, H Kollberg, Marie Johannesson, et al.. (2007). More Than 10 Years' Continuous Oral Treatment with Specific Immunoglobulin Y for the Prevention of Pseudomonas aeruginosa Infections: A Case Report. Journal of Medicinal Food. 10(2). 375–378. 44 indexed citations
5.
Kollberg, H, David Carlander, Hanne Vebert Olesen, et al.. (2003). Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study. Pediatric Pulmonology. 35(6). 433–440. 100 indexed citations
6.
Carlander, David, H Kollberg, & Anders Larsson. (2002). Retention of Specific Yolk IgY in the Human Oral Cavity. BioDrugs. 16(6). 433–437. 19 indexed citations
7.
Carlander, David, et al.. (2000). Peroral immunotheraphy with yolk antibodies for the prevention and treatment of enteric infections. Immunologic Research. 21(1). 1–6. 160 indexed citations
8.
Carlander, David, et al.. (1999). Immunoglobulin Y (IgY) A new tool for the prophylaxis against Pseudomonas aeruginosa in cystic fibrosis patients. Pediatric Pulmonology. 240. 5 indexed citations
9.
Kollberg, H. (1999). [Cystic fibrosis--an ancient disease with renewed topicality. History and clinical practice].. PubMed. 96(30-31). 3324–9. 1 indexed citations
10.
Kollberg, H, Anders Larsson, & David Carlander. (1998). More than four years without any new pseudomonas infections at Uppsala Cystic fibrosis centre.. 17. 313. 3 indexed citations
11.
Dahl, Niklas, Ulla Grandell, Tommy Martinsson, et al.. (1993). Frequency of four cystic fibrosis mutations in a Swedish population. Acta Paediatrica. 82(6-7). 609–609. 7 indexed citations
12.
Kollberg, H, et al.. (1988). Dopamine and Catecholamines in Cystic Fibrosis in Response to a Marathon Race. International Journal of Sports Medicine. 9(S 1). S56–S59. 3 indexed citations
13.
Stanghelle, Johan Kvalvik, et al.. (1988). Biochemical Changes and Endocrine Responses in Cystic Fibrosis in Relation to Incremental Maximal Exhaustive Exercise. International Journal of Sports Medicine. 9(S 1). S41–S44. 1 indexed citations
14.
Kollberg, H. (1988). Cystic Fibrosis and Physical Activity: An Introduction. International Journal of Sports Medicine. 9(S 1). S2–S5. 5 indexed citations
15.
Kollberg, H, et al.. (1988). Fatty Acids in Cystic Fibrosis in Response to a Marathon Race. International Journal of Sports Medicine. 9(S 1). S51–S55. 2 indexed citations
16.
Kollberg, H. (1986). Cystic Fibrosis in Kuwait. Journal of Tropical Pediatrics. 32(6). 293–294. 12 indexed citations
17.
Roomans, Godfried M., et al.. (1981). Electrolyte Redistribution in Cystic Fibrosis Fibroblasts Studied by Electron Probe Xray Microanalysis. Ultrastructural Pathology. 2(1). 53–58. 17 indexed citations
18.
Kollberg, H, et al.. (1979). Lead concentrations in the blood of children in the vicinity of a sulfide-ore smelting plant. An evaluation of the influence of various sources of lead pollution in the children's environment.. AMBIO. 8. 118–120. 4 indexed citations
19.
Kollberg, H & Krister Hellsing. (1972). Screening for cystic fibrosis.. Archives of Disease in Childhood. 47(255). 836–836. 7 indexed citations
20.
Kollberg, H. (1969). [The diagnosis and treatment of mucoviscidosis (cystic fibrosis of the pancreas)].. PubMed. 66(29). 2929–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. C. Roberts Breakdown of academic impact, for papers by Shota Yamamoto Breakdown of academic impact, for papers by Jill Beech Breakdown of academic impact, for papers by H. Platt Breakdown of academic impact, for papers by Manuela Rinaldi Breakdown of academic impact, for papers by Howard B. Gelberg Breakdown of academic impact, for papers by Myriam Bélanger Breakdown of academic impact, for papers by Iwan A. Burgener Breakdown of academic impact, for papers by M. Oikawa Breakdown of academic impact, for papers by Brendan C. McKiernan
Rankless by CCL
2026